Impact of polyunsaturated fatty acids on oxidized low density lipoprotein-induced U937 cell apoptosis.

AIM Dietary supplements in polyunsaturated fatty acids (PUFA), particularly omega-3, are well known for their beneficial effects in preventing cardiovascular diseases (CVD). The aim of this study was to determine the role of PUFA on the modulation of apoptosis induced by hypochlorous acidoxidized LDL (HOCl-oxLDL) in U937 cells. METHODS We tested the effect of monocyte cell line U937 supplementation with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (ARA) or oleic acid (OA) on the modulation of HOCl-oxLDL-induced apoptosis. RESULTS First, we showed the incorporation of fatty acids in the cellular membrane in U937 cells. Then, we showed that both EPA and ARA exerted a pro-apoptotic effect through the intrinsic mitochondrial apoptotic pathway including the dissipation of mitochondrial membrane potential followed by cardiolipin depletion, the downstream activation of caspase-3 and the increase in DNA fragmentation. The pro-apoptotic effect of EPA or ARA was completely blocked in U937/Bcl-2 cells. CONCLUSIONS A new mechanism of dietary supplements in PUFA with likely consequences in apoptosis could be suggested through the mitochondrial pathway in monocytes.

[1]  W. Schunck,et al.  Cytochrome P450-dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids , 2010 .

[2]  B. Lacour,et al.  Differential apoptotic pathways activated in response to Cu-induced or HOCl-induced LDL oxidation in U937 monocytic cell line. , 2010, Biochemical and biophysical research communications.

[3]  W. Schunck,et al.  Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids. , 2010, Pharmacological reports : PR.

[4]  A. Lichtenstein,et al.  Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse. , 2009, Atherosclerosis.

[5]  B. Lacour,et al.  Protective Effects of EPA and Deleterious Effects of DHA on eNOS Activity in Ea hy 926 Cultured with Lysophosphatidylcholine , 2009, Lipids.

[6]  M. Mitjavila,et al.  Atherosclerosis prevention by a fish oil-rich diet in apoE(-/-) mice is associated with a reduction of endothelial adhesion molecules. , 2008, Atherosclerosis.

[7]  B. Lacour,et al.  Role of reactive oxygen species and Bax in oxidized low density lipoprotein-induced apoptosis of human monocytes. , 2008, Atherosclerosis.

[8]  M. Lagarde,et al.  Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis , 2008, British Journal of Nutrition.

[9]  R. Nagai,et al.  Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. , 2008, Atherosclerosis.

[10]  U. Jung,et al.  n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[11]  D. Reen,et al.  Induction and modulation of apoptosis in neonatal monocytes by polyunsaturated fatty acids. , 2007, Journal of pediatric surgery.

[12]  Zuyuan Xu,et al.  Fish oil significantly alters fatty acid profiles in various lipid fractions but not atherogenesis in apo E-KO mice , 2007, European journal of nutrition.

[13]  Dariush Mozaffarian,et al.  Fish intake, contaminants, and human health: evaluating the risks and the benefits. , 2006, JAMA.

[14]  B. Lacour,et al.  Lipid metabolism in human endothelial cells. , 2006, Biochimica et biophysica acta.

[15]  I. Tabas.  Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis: The Importance of Lesion Stage and Phagocytic Efficiency , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J. Skepper,et al.  Potency of arachidonic acid in polyunsaturated fatty acid-induced death of human monocyte-macrophages: implications for atherosclerosis. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[17]  Z. Massy,et al.  Apoptotic pathways involved in U937 cells exposed to LDL oxidized by hypochlorous acid. , 2003, Free radical biology & medicine.

[18]  Jianglin Fan,et al.  Inflammatory reactions in the pathogenesis of atherosclerosis. , 2003, Journal of atherosclerosis and thrombosis.

[19]  P. Calder,et al.  Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial , 2003, The Lancet.

[20]  A. Simopoulos,et al.  The importance of the ratio of omega-6/omega-3 essential fatty acids. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  A. Tedgui,et al.  Apoptosis in the vasculature: mechanisms and functional importance , 2000, British journal of pharmacology.

[22]  A. Herman,et al.  Apoptosis in atherosclerosis: beneficial or detrimental? , 2000, Cardiovascular research.

[23]  J. Heinecke.  Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis , 1997, Current opinion in lipidology.

[24]  B. Björkerud,et al.  Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. , 1996, The American journal of pathology.

[25]  R. Stocker,et al.  Presence of hypochlorite-modified proteins in human atherosclerotic lesions. , 1996, The Journal of clinical investigation.

[26]  Michael Ginsberg,et al.  Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  WolfgangSattler,et al.  Immunologic Detection and Measurement of Hypochlorite-Modified LDL With Specific Monoclonal Antibodies , 1995 .

[28]  R. Stocker,et al.  Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. , 1995, Arteriosclerosis, Thrombosis and Vascular Biology.

[29]  A. Daugherty,et al.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.

[30]  E. Oliw,et al.  Metabolism of polyunsaturated (n-3) fatty acids by monkey seminal vesicles: isolation and biosynthesis of omega-3 epoxides. , 1991, Biochimica et biophysica acta.

[31]  M. Brown,et al.  Atherosclerosis. Scavenging for receptors. , 1990, Nature.

[32]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[33]  D. Horrobin,et al.  Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. , 1988, Journal of the National Cancer Institute.

[34]  D. Steinberg,et al.  Lipoproteins and the pathogenesis of atherosclerosis. , 1987, Circulation.

[35]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[36]  P. Dagnelie,et al.  Théorie et méthodes statistiques. Exercices. , 1982 .

[37]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Dyerberg,et al.  The composition of food consumed by Greenland Eskimos. , 2009, Acta medica Scandinavica.

[39]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[40]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.